• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Ignota Labs

To add a bio or update company history, please click update information.

News from Ignota Labs

    Ignota Labs raises £5.5m seed led by Montage Ventures and AIX Ventures to turn around failed drugsIgnota Labs raises £5.5m seed led by Montage Ventures and AIX Ventures to turn around failed drugs
    Ignota Labs
    26 Feb 2025

    Ignota Labs raises £5.5m seed led by Montage Ventures and AIX Ventures to turn around failed drugs

    Ignota Labs applies AI-driven drug discovery to rescue and redevelop failed drug candidates, identifying and resolving safety issues so promising therapies can be revived and progressed back into clinical development.

Ignota Labs
  • Life Sciences
  • Cambridge, United Kingdom
  • £5.5m
  • ignotalabs.ai
  • Update Information

More venture news

  • Perceptic raises a £9m seed round led by Accel to unify drug discovery and development on a single AI platform
    Perceptic
    28 May 2026

    Perceptic raises a £9m seed round led by Accel to unify drug discovery and development on a single AI platform

    SeedLife Sciences
  • Imperagen secures a £5m seed round led by PXN Ventures to accelerate the process of enzyme engineering
    Imperagen
    21 May 2026

    Imperagen secures a £5m seed round led by PXN Ventures to accelerate the process of enzyme engineering

    SeedLife Sciences
  • Infex Therapeutics secures £4.3m in funding led by Jon Moulton for antimicrobial resistance treatments
    Infex Therapeutic
    12 May 2026

    Infex Therapeutics secures £4.3m in funding led by Jon Moulton for antimicrobial resistance treatments

    EquityLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn